Carolin Ertl
Overview
Explore the profile of Carolin Ertl including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
6
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ertl C, Tomsitz D, Ben Khaled N
Inn Med (Heidelb)
. 2024 Aug;
65(9):899-911.
PMID: 39115593
Immune checkpoint inhibitors (ICI) represent a breakthrough in cancer therapy. They are effective in various tumor entities and can be used in more and more treatment settings. This leads to...
2.
Wang Y, Ertl C, Schmitt C, Hammann L, Kramer R, Grabmaier U, et al.
Front Cardiovasc Med
. 2024 Jun;
11:1408586.
PMID: 38915743
Background: Immune checkpoint inhibitor (ICI)-induced myocarditis is a rare immune-related adverse event (irAE) with a fatality rate of 40%-46%. However, irMyocarditis can be asymptomatic. Thus, improved monitoring, detection and therapy...
3.
Ruf T, Kramer R, Forschner A, Leiter U, Meier F, Reinhardt L, et al.
Eur J Cancer
. 2024 Apr;
203:114028.
PMID: 38652976
Background: Immune checkpoint inhibitors (ICI) induce adverse events (irAEs) that do not respond to steroids, i.e. steroid-refractory (sr) irAEs, and irAEs in which steroids cannot be tapered, i.e. steroid-dependent (sd)...
4.
Ertl C, Ruf T, Mentzer D, Kong M, Kramer R, von Bergwelt-Baildon M, et al.
Eur J Cancer
. 2024 Jan;
199:113505.
PMID: 38262306
Background: Immunotherapies such as immune checkpoint inhibitors (ICI) are effective in multiple tumor entities but induce a plethora of side effects. Comprehensive real-world analyses are essential to identify new signals,...
5.
Joost S, Schweiger F, Pfeiffer F, Ertl C, Keiler J, Frank M, et al.
Front Cell Neurosci
. 2022 Mar;
16:709596.
PMID: 35250482
Myelin damage is a histopathological hallmark of multiple sclerosis lesions. Results of studies suggest that impaired myelin-axon interaction characterized by focal myelin detachments is an early event during lesion genesis....